Miromatrix Medical Inc
NASDAQ:MIRO
Intrinsic Value
Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. [ Read More ]
The intrinsic value of one MIRO stock under the Base Case scenario is 0.04 USD. Compared to the current market price of 3.39 USD, Miromatrix Medical Inc is Overvalued by 99%.
Valuation Backtest
Miromatrix Medical Inc
Run backtest to discover the historical profit from buying and selling MIRO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Miromatrix Medical Inc
Current Assets | 17.2m |
Cash & Short-Term Investments | 16.1m |
Receivables | 90k |
Other Current Assets | 1m |
Non-Current Assets | 6.2m |
PP&E | 6.2m |
Current Liabilities | 5m |
Accounts Payable | 1.1m |
Accrued Liabilities | 3m |
Other Current Liabilities | 880k |
Non-Current Liabilities | 2.9m |
Long-Term Debt | 390k |
Other Non-Current Liabilities | 2.5m |
Earnings Waterfall
Miromatrix Medical Inc
Revenue
|
960k
USD
|
Cost of Revenue
|
-500k
USD
|
Gross Profit
|
460k
USD
|
Operating Expenses
|
-29.1m
USD
|
Operating Income
|
-28.6m
USD
|
Other Expenses
|
1.2m
USD
|
Net Income
|
-27.4m
USD
|
Free Cash Flow Analysis
Miromatrix Medical Inc
MIRO Profitability Score
Profitability Due Diligence
Miromatrix Medical Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
Score
Miromatrix Medical Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
MIRO Solvency Score
Solvency Due Diligence
Miromatrix Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Miromatrix Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MIRO Price Targets Summary
Miromatrix Medical Inc
According to Wall Street analysts, the average 1-year price target for MIRO is 3.13 USD .
Ownership
MIRO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MIRO Price
Miromatrix Medical Inc
Average Annual Return | -68.96% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -94% |
Market Capitalization | 93m USD |
Shares Outstanding | 27 419 200 |
Percentage of Shares Shorted | 0.04% |
MIRO News
Last Important Events
Miromatrix Medical Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Miromatrix Medical Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company is headquartered in Eden Prairie, Minnesota and currently employs 61 full-time employees. The company went IPO on 2021-06-24. The firm is engaged in providing the technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company’s technology platform uses a two-step method of decellularization and recellularization. Its development focus is on bioengineering livers and kidneys, and its technology platform is also applicable to bioengineering other organs, including hearts, lungs, and pancreases. Decellularization is a process that is designed to remove porcine cells from the organs obtained from pigs to create a purified acellular extracellular matrix (ECM). Its perfusion process purifies the organs while preserving the mechanical structures and vascular networks. Recellularization is a process that incorporates perfusion to re-seed the ECM with unmodified human cells inside individual bioreactors. The firm's product pipeline includes miroliver, mirokidney, miroheart, mirolung and miropancreas.
Contact
IPO
Employees
Officers
The intrinsic value of one MIRO stock under the Base Case scenario is 0.04 USD.
Compared to the current market price of 3.39 USD, Miromatrix Medical Inc is Overvalued by 99%.